Top Menu

Author Archive | IRF

IRF News

PRESS RELEASE 30/3/15

from Press Dispensary Court of Appeals rules HIV not likely to be spread through unprotected sex In a landmark legal case that has received little attention outside the United States, the highest military court in the US recently overturned decades of judgements regarding the likelihood of spreading HIV through unprotected sex. In late February, the […]

Continue Reading
IRF News

Gutierrez Press Release

Below is Press Dispensary press release and right at the end is the legal assessment by Clark Baker who runs OMSJ in US – Office of Medical and Scientific Justice. Click on link below for the online presentation. Online presentation: http://bit.ly/HIVappeal PRESS RELEASE   30/3/15 from Press Dispensary Court of Appeals rules HIV not likely […]

Continue Reading
Professor Etienne de Harven, MD

Measuring “Viral load” does not prove the existence of a hypothetical HIV.

By Etienne de Harven, M.D. When PCR methodologies are clinically applied to measure the so-called “ Viral load “, results do not permit to quantify, in any way, the number of HIV particles hypothetically present in the circulating blood of AIDS patients.  Demonstrating retroviral particles using the electron microscope, directly in patient’s blood samples, and without any passage […]

Continue Reading
IRF News

How Positive Are You? Podcast Interview with Joan Shenton

How Positive Are You? Episode 72: Joan Shenton’s ‘Positive Hell’ and Heavenly Web Site – Go to Podcast ‘Journalist Joan Shenton interviewed a cluster of healthy “HIV positives” in Spain for her upcoming documentary, Positive Hell (with producer/director Andi Reiss). She talks with David and Beth about this project and about her nonprofit organization’s recently relaunched Web site – an extremely valuable […]

Continue Reading
IRF News

Re-examining AIDS – Interview

http://www.youtube.com/watch?v=0kOeLbrX3pk The world has lived under the shadow of AIDS since it was officially recognized by the Center for Disease Control (CDC) in 1981. In the last three decades, national and international health organizations and pharmaceutical companies have conducted a great deal of research — and considerably shifted the public’s perception of sex. Today, we […]

Continue Reading
IRF News

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

DNA prime–recombinant adenovirus type 5 boost (DNA/rAd5) vaccine regimen in persons at increased risk for HIV-1 infection in the United States backfired and was stopped because the “vaccination regime” increased the risk of getting “iHIV-infected”. Source and details: http://www.nejm.org/doi/full/10.1056/NEJMoa1310566?query=TOC

Continue Reading